Advocates On Guard As SCOTUS Punts Mifepristone Case To Lower Court

The Supreme Court’s recent decision to punt back to a lower court a case over FDA’s in-person prescribing requirements for the abortion pill mifepristone has women’s health advocates, who oppose the requirements, on guard. One points out that Amy Coney Barrett's expected Supreme Court confirmation could further jeopardize the lower courts mifepristone ruling, should the case return to the high court, while others note there are also myriad other cases on their way to the Supreme Court that will affect...